Published in Blood Weekly, January 8th, 2004
Data from a pilot study presented by Francesco Iuliano, MD, Hematology-Oncology Dept., Azienda Ospedaliera Pugliese Ciaccio, Catanzaro, Italy, and coauthored by Elisabetta Abruzzese, MD, PhD, Division of Hematology, S. Eugenio Hospital at University of Tor Vergata, Rome, Italy, showed that Quadramet, in combination with zoledronic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.